The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
Open accessAbstract
Epidemiological studies suggest a positive association between obesity and type 2 diabetes mellitus (T2D) with the risk of cancer and cancer-related mortality. Insulin resistance, hyperinsulinemia, increased levels of IGF, elevated levels of steroid and peptide hormones, and inflammatory markers appear to play a role in the connection between these different diseases. Medications, such as metformin and exogenous insulin, used to treat T2D may affect the risk of cancer and cancer-related mortality. Newer therapies targeting the insulin and IGF1 systems are being developed for use in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Eltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Biological Action of Leptin as an Angiogenic Factor
Sierra-Honigmann, M. R., Nath, A. K., Murakami, C., Garcı́a-Cardeña, G., Papapetropoulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini, P. J., et al. (1998) · Science · doi:10.1126/science.281.5383.1683 · Cited by 1,371
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
The insulin-like growth factor system and cancer
LeRoith, D., & Roberts, C. T. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00159-9 · Cited by 1,124
Self-citationType-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Self-citationFasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 988
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and Older
Yancik, R. (2001) · JAMA · doi:10.1001/jama.285.7.885 · Cited by 896
Barone, B. B. (2008) · JAMA · doi:10.1001/jama.2008.824 · Cited by 881 · cited 1×
“Suggested explanations for this worse outcome and increased mortality include increased proliferation of tumor cells triggered by higher concentrations of insulin, IGF, and glucose (Barone et al. 2008).”
BackgroundJiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 3×
“Jiralerspong et al .”
InfluentialDiabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
Sahra, I. B., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J. F., Le Marchand-Brustel, Y., & Bost, F. (2008) · Oncogene · doi:10.1038/sj.onc.1211024 · Cited by 861
Effect of fasting on serum leptin in normal human subjects
Boden, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3419 · Cited by 809
Overweight as an avoidable cause of cancer in Europe
Bergström, A., Pisani, P., Tenet, V., Wolk, A., & Adami, H. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1053>3.0.co;2-t · Cited by 758
Bråkenhielm, E., Veitonmäki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B., Funahashi, T., & Cao, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308671100 · Cited by 732
Leptin, the Product of Ob Gene, Promotes Angiogenesis
Bouloumié, A., Drexler, H. C. A., Lafontan, M., & Busse, R. (1998) · Circulation Research · doi:10.1161/01.res.83.10.1059 · Cited by 715
Adipose Tissue as an Endocrine Organ
Ahima, R. S. (2006) · Obesity · doi:10.1038/oby.2006.317 · Cited by 640
A Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal Women
Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., & Pasternack, B. S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.190 · Cited by 620
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
Kaaks, R., & Lukanova, A. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200070 · Cited by 615
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607 · cited 1×
“The potential for increased cancer risk in patients treated with insulin analogs became a cause of alarm after a German study showed a dose-dependent increase in cancer risk in patients treated with one such analog, insulin glargine, compared with human insulin (Hemkens et al. 2009).”
Garofalo, C., & Surmacz, E. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20472 · Cited by 588
Adipose Tissue: The New Endocrine Organ? A Review Article
Wozniak, S. E., Gee, L. L., Wachtel, M. S., & Frezza, E. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0585-3 · Cited by 588
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Adiponectin and Breast Cancer Risk
Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031804 · Cited by 533
Kaaks, R., Rinaldi, S., Key, T. J., Berrino, F., Peeters, P. H. M., Biessy, C., Dossus, L., Lukanova, A., Bingham, S., Khaw, K.-T., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01038 · Cited by 527
Alimova, I. N., Liu, B., Fan, Z., Edgerton, S. M., Dillon, T., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7933 · Cited by 523
Obesity and Breast Cancer: The Estrogen Connection
Cleary, M. P., & Grossmann, M. E. (2009) · Endocrinology · doi:10.1210/en.2009-0070 · Cited by 504
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
Ben Sahra, I., Le Marchand-Brustel, Y., Tanti, J.-F., & Bost, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1186 · Cited by 493
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
Adiponectin and cancer: a systematic review
Kelesidis, I., Kelesidis, T., & Mantzoros, C. S. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603051 · Cited by 487
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Grossmann, M., Thomas, M. C., Panagiotopoulos, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., & Jerums, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2177 · Cited by 468
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Maffei, M., Fei, H., Lee, G. H., Dani, C., Leroy, P., Zhang, Y., Proenca, R., Negrel, R., Ailhaud, G., & Friedman, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6957 · Cited by 465
Park, H.-Y., Kwon, H. M., Lim, H. J., Hong, B. K., Lee, J. Y., Park, B. E., Jang, Y. S., Cho, S. Y., & Kim, H.-S. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.17 · Cited by 464
Brown, N. S., & Bicknell, R. (2001) · Breast Cancer Research · doi:10.1186/bcr315 · Cited by 462
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Peairs, K. S., Barone, B. B., Snyder, C. F., Yeh, H.-C., Stein, K. B., Derr, R. L., Brancati, F. L., & Wolff, A. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3011 · Cited by 449
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF
Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J., & Cao, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101564798 · Cited by 446
Ma, J., Li, H., Giovannucci, E., Mucci, L., Qiu, W., Nguyen, P. L., Gaziano, J. M., Pollak, M., & Stampfer, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70235-3 · Cited by 421
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Frasca, F., Pandini, G., Sciacca, L., Pezzino, V., Squatrito, S., Belfiore, A., & Vigneri, R. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801969715 · Cited by 410
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
SDRN Epidemiology Group, & Colhoun, H. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1453-1 · Cited by 393
Amling, C. L., Riffenburgh, R. H., Sun, L., Moul, J. W., Lance, R. S., Kusuda, L., Sexton, W. J., Soderdahl, D. W., Donahue, T. F., Foley, J. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.132 · Cited by 385
Functionally distinct insulin receptors generated by tissue-specific alternative splicing.
Mosthaf, L., Grako, K., Dull, T. J., Coussens, L., Ullrich, A., & McClain, D. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07416.x · Cited by 366
Tumour necrosis factor-α as a tumour promoter
Szlosarek, P., Charles, K. A., & Balkwill, F. R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.012 · Cited by 366
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue, F., & Michels, K. B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.823s · Cited by 353
Minireview: IGF, Insulin, and Cancer
Gallagher, E. J., & LeRoith, D. (2011) · Endocrinology · doi:10.1210/en.2011-0231 · Cited by 349
Self-citationType 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study
Michels, K. B., Solomon, C. G., Hu, F. B., Rosner, B. A., Hankinson, S. E., Colditz, G. A., & Manson, J. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1752 · Cited by 341
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
Clemmons, D. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2359 · Cited by 340
Lee, A. V. (1999) · Molecular Endocrinology · doi:10.1210/me.13.5.787 · Cited by 340
Association of Obesity and Cancer Risk in Canada
Pan, S. Y. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh041 · Cited by 339
Cantrell, L. A., Zhou, C., Mendivil, A., Malloy, K. M., Gehrig, P. A., & Bae-Jump, V. L. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.09.024 · Cited by 331
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 329
Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C., Allred, D. C., & Osborne, C. K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114315 · Cited by 328
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways
Levine, A. J., Feng, Z., Mak, T. W., You, H., & Jin, S. (2006) · Genes & Development · doi:10.1101/gad.1363206 · Cited by 321
Kisfalvi, K., Eibl, G., Sinnett-Smith, J., & Rozengurt, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0418 · Cited by 315
Reiling, J. H., & Sabatini, D. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209889 · Cited by 311
Hormonal Predictors of Prostate Cancer: A Meta-Analysis
Shaneyfelt, T., Husein, R., Bubley, G., & Mantzoros, C. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.847 · Cited by 310
Sciacca, L., Costantino, A., Pandini, G., Mineo, R., Frasca, F., Scalia, P., Sbraccia, P., Goldfine, I. D., Vigneri, R., & Belfiore, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202600 · Cited by 288
Leptin mediates a proliferative response in human MCF7 breast cancer cells
Dieudonne, M.-N., Machinal-Quelin, F., Serazin-Leroy, V., Leneveu, M.-C., Pecquery, R., & Giudicelli, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00205-x · Cited by 285
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Self-citationBMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Carboni, J. M., Wittman, M., Yang, Z., Lee, F., Greer, A., Hurlburt, W., Hillerman, S., Cao, C., Cantor, G. H., Dell-John, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0499 · Cited by 280
BAILYES, E. M., NAVÉ, B. T., SOOS, M. A., ORR, S. R., HAYWARD, A. C., & SIDDLE, K. (1997) · Biochemical Journal · doi:10.1042/bj3270209 · Cited by 278
Soos, M. A., Field, C. E., & Siddle, K. (1993) · Biochemical Journal · doi:10.1042/bj2900419 · Cited by 275
Belfiore, A., & Malaguarnera, R. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0074 · Cited by 272
Haluska, P., Shaw, H. M., Batzel, G. N., Yin, D., Molina, J. R., Molife, L. R., Yap, T. A., Roberts, M. L., Sharma, A., Gualberto, A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1118 · Cited by 270
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
Rapp, K., Schroeder, J., Klenk, J., Ulmer, H., Concin, H., Diem, G., Oberaigner, W., & Weiland, S. K. (2006) · Diabetologia · doi:10.1007/s00125-006-0207-6 · Cited by 270
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Manson, J. E., Li, J., Harris, T. G., Rohan, T. E., Xue, X., Ho, G. Y. F., et al. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2686 · Cited by 267
Hypoxia-inducible Factor 1 Transactivates the Human Leptin Gene Promoter
Grosfeld, A., André, J., Hauguel-de Mouzon, S., Berra, E., Pouysségur, J., & Guerre-Millo, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206775200 · Cited by 263
Pandini, G., Vigneri, R., Costantino, A., Frasca, F., Ippolito, A. M., Fujita‐Yamaguchi, Y., Siddle, K., Goldfine, I. D., & Belfiore, A. (1999) · PubMed · Cited by 255
Arteaga, C. L., & Osborne, C. K. (1989) · PubMed · Cited by 254
Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats
Braden, L. M., & Carroll, K. K. (1986) · Lipids · doi:10.1007/bf02536414 · Cited by 245
Rinaldi, S., Cleveland, R., Norat, T., Biessy, C., Rohrmann, S., Linseisen, J., Boeing, H., Pischon, T., Panico, S., Agnoli, C., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.24927 · Cited by 244
Vella, V. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.245 · Cited by 239
Transcriptional and post-translational regulation of adiponectin
Liu, M., & Liu, F. (2010) · Biochemical Journal · doi:10.1042/bj20091045 · Cited by 235
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Howard, B. V., Wylie-Rosett, J., Anderson, G. L., Ho, G. Y. F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2946 · Cited by 229
Metformin attenuates ovarian cancer cell growth in an AMP‐kinase dispensable manner
Rattan, R., Giri, S., Hartmann, L. C., & Shridhar, V. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00954.x · Cited by 223
Obesity and risk of cancer in Japan
Kuriyama, S., Tsubono, Y., Hozawa, A., Shimazu, T., Suzuki, Y., Koizumi, Y., Suzuki, Y., Ohmori, K., Nishino, Y., & Tsuji, I. (2005) · International Journal of Cancer · doi:10.1002/ijc.20529 · Cited by 213
Plasma Adiponectin Levels and Endometrial Cancer Risk in Pre- and Postmenopausal Women
Cust, A. E., Kaaks, R., Friedenreich, C., Bonnet, F., Laville, M., Lukanova, A., Rinaldi, S., Dossus, L., Slimani, N., Lundin, E., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1371 · Cited by 210
Yakar, S., LeRoith, D., & Brodt, P. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.010 · Cited by 200
Self-citationAdiponectin as a growth inhibitor in prostate cancer cells
Bub, J. D., Miyazaki, T., & Iwamoto, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.103 · Cited by 198
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor
Ish-Shalom, D., Christoffersen, C. T., Vorwerk, P., Sacerdoti-Sierra, N., Shymko, R. M., Naor, D., & Meyts, P. D. (1997) · Diabetologia · doi:10.1007/s001250051393 · Cited by 193
Transcriptional Activation of the Human Leptin Gene in Response to Hypoxia
Ambrosini, G., Nath, A. K., Sierra-Honigmann, M. R., & Flores-Riveros, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205172200 · Cited by 189
Prostate Cancer Cell-Adipocyte Interaction
Onuma, M., Bub, J. D., Rummel, T. L., & Iwamoto, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304984200 · Cited by 189
Clinically Defined Type 2 Diabetes Mellitus and Prognosis in Early-Stage Breast Cancer
Erickson, K., Patterson, R. E., Flatt, S. W., Natarajan, L., Parker, B. A., Heath, D. D., Laughlin, G. A., Saquib, N., Rock, C. L., & Pierce, J. P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.3183 · Cited by 189
Jenab, M., Riboli, E., Cleveland, R. J., Norat, T., Rinaldi, S., Nieters, A., Biessy, C., Tjønneland, A., Olsen, A., Overvad, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22697 · Cited by 187
Zeleniuch-Jacquotte, A., Shore, R. E., Koenig, K. L., Akhmedkhanov, A., Afanasyeva, Y., Kato, I., Kim, M. Y., Rinaldi, S., Kaaks, R., & Toniolo, P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601517 · Cited by 186
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
Algire, C., Zakikhani, M., Blouin, M.-J., Shuai, J. H., & Pollak, M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0038 · Cited by 185
Venkateswaran, V., Haddad, A. Q., Fleshner, N. E., Fan, R., Sugar, L. M., Nam, R., Klotz, L. H., & Pollak, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm231 · Cited by 182
Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B., & Hue, L. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1178 · Cited by 180
Haluska, P., Carboni, J. M., Loegering, D. A., Lee, F. Y., Wittman, M., Saulnier, M. G., Frennesson, D. B., Kalli, K. R., Conover, C. A., Attar, R. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1107 · Cited by 179
Prostate cancer cell proliferation is influenced by leptin1
Somasundar, P. S., Frankenberry, K. A., Skinner, H. D., Vedula, G., McFadden, D. W., Riggs, D. R., Jackson, B., VanGilder, R. L., Hileman, S. M., & Vona-Davis, L. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.01.017 · Cited by 170
Endo, H., Hosono, K., Uchiyama, T., Sakai, E., Sugiyama, M., Takahashi, H., Nakajima, N., Wada, K., Takeda, K., Nakagama, H., et al. (2011) · Gut · doi:10.1136/gut.2010.235754 · Cited by 166
Genetically Obese MMTV-TGF-α/Lep ob Lep ob Female Mice do not Develop Mammary Tumors
Cleary, M. P., Phillips, F. C., Getzin, S. C., Jacobson, T. L., Jacobson, M. K., Christensen, T. A., Juneja, S. C., Grande, J. P., & Maihle, N. J. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021891825399 · Cited by 165
del Rincon, J.-P., Iida, K., Gaylinn, B. D., McCurdy, C. E., Leitner, J. W., Barbour, L. A., Kopchick, J. J., Friedman, J. E., Draznin, B., & Thorner, M. O. (2007) · Diabetes · doi:10.2337/db06-0299 · Cited by 164
Lacy, M. Q., Alsina, M., Fonseca, R., Paccagnella, M. L., Melvin, C. L., Yin, D., Sharma, A., Enriquez Sarano, M., Pollak, M., Jagannath, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9319 · Cited by 163
Sciacca, L., Mineo, R., Pandini, G., Murabito, A., Vigneri, R., & Belfiore, A. (2002) · Oncogene · doi:10.1038/sj.onc.1206058 · Cited by 162
Associations between adipokines and obesity-related cancer
Paz-Filho, G., Lim, E. L., Wong, M.-L., & Licinio, J. (2010) · Frontiers in bioscience · doi:10.2741/3810 · Cited by 159
Bosco, J. L. F., Antonsen, S., Sørensen, H. T., Pedersen, L. H., & Lash, T. L. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0817 · Cited by 151
IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
Perks, C. M., Vernon, E. G., Rosendahl, A. H., Tonge, D. W., & Holly, J. M. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210397 · Cited by 143
Kim, K.-Y., Baek, A., Hwang, J.-E., Choi, Y. A., Jeong, J., Lee, M.-S., Cho, D. H., Lim, J., Kim, K. I., & Yang, Y. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2641 · Cited by 142
Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database
Freedland, S. J., Bañez, L. L., Sun, L. L., Fitzsimons, N. J., & Moul, J. W. (2009) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2009.11 · Cited by 138
Mortality From Site-Specific Malignancies in Type 2 Diabetic Patients From Verona
Verlato, G., Zoppini, G., Bonora, E., & Muggeo, M. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1047 · Cited by 138
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Cazzaniga, M., Bonanni, B., Guerrieri‐Gonzaga, A., & DeCensi, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0871 · Cited by 134
Goya, M., Miyamoto, S., Nagai, K., Ohki, Y., Nakamura, K., Shitara, K., Maeda, H., Sangai, T., Kodama, K., Endoh, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0919 · Cited by 131
Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells
Zhou, J., Huang, W., Tao, R., Ibaragi, S., Lan, F., Ido, Y., Wu, X., Alekseyev, Y. O., Lenburg, M. E., Hu, G.-F., et al. (2009) · Oncogene · doi:10.1038/onc.2009.63 · Cited by 129
Modulation by leptin of proliferation and apoptosis in vascular endothelial cells
Artwohl, M., Roden, M., Hölzenbein, T., Freudenthaler, A., Waldhäusl, W. K., & Baumgartner-Parzer, S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801947 · Cited by 122
Dietary fat and mammary carcinogenesis
Carroll, K. K., & Braden, L. M. (1985) · Nutrition and Cancer · doi:10.1080/01635588509513831 · Cited by 121
Effect of Insulin on Cell Cycle Progression in MCF-7 Breast Cancer Cells
Chappell, J., Leitner, J. W., Solomon, S. R., Golovchenko, I., Goalstone, M. L., & Draznin, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104416200 · Cited by 110
Chen, W., Wang, S., Tian, T., Bai, J., Hu, Z., Xu, Y., Dong, J., Chen, F., Wang, X., & Shen, H. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.86 · Cited by 110
Ruiter, R., Visser, L. E., van Herk‐Sukel, M. P. P., Coebergh, J. W. W., Haak, H. R., Geelhoed-Duijvestijn, P. H. L. M., Straus, S. M. J. M., Herings, R. M. C., & Stricker, B. H. C. (2011) · Diabetologia · doi:10.1007/s00125-011-2312-4 · Cited by 110
Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden
Stocks, T., Lukanova, A., Rinaldi, S., Biessy, C., Dossus, L., Lindahl, B., Hallmans, G., Kaaks, R., & Stattin, P. E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22587 · Cited by 109
McTernan, P. G., Anwar, A., Eggo, M., Barnett, A. H., Stewart, P., & Kumar, S. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801254 · Cited by 107
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer
Belfiore, A., Pandini, G., Vella, V., Squatrito, S., & Vigneri, R. (1999) · Biochimie · doi:10.1016/s0300-9084(99)80088-1 · Cited by 106
Prostate-specific Antigen Values in Diabetic and Nondiabetic US Men, 2001–2002
Werny, D. M., Saraiya, M., & Gregg, E. W. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj311 · Cited by 102
Medical comorbidities predict mortality in women with a history of early stage breast cancer
Patterson, R. E., Flatt, S. W., Saquib, N., Rock, C. L., Caan, B. J., Parker, B. A., Laughlin, G. A., Erickson, K. D., Thomson, C. A., Bardwell, W. A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0732-3 · Cited by 97
Long-term effects of insulin glargine on the risk of breast cancer
Suissa, S., Azoulay, L., Dell’Aniello, S., Evans, M., Vora, J. P., & Pollak, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2190-9 · Cited by 97
Effect of Adiponectin and Ghrelin on Apoptosis of Barrett Adenocarcinoma Cell Line
Konturek, P. C., Burnat, G., Rau, T. T., Hahn, E. G., & Konturek, S. J. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9922-1 · Cited by 96
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2009) · Diabetes · doi:10.2337/db09-1291 · Cited by 93
Self-citationSachdev, D., Zhang, X., Matise, I., Gaillard-Kelly, M., & Yee, D. (2009) · Oncogene · doi:10.1038/onc.2009.316 · Cited by 93
Obesity Accelerates Mouse Mammary Tumor Growth in the Absence of Ovarian Hormones
Núñez, N. P., Perkins, S. N., Smith, N. C. P., Berrigan, D. A., Berendes, D. M., Varticovski, L., Barrett, J. C., & Hursting, S. D. (2008) · Nutrition and Cancer · doi:10.1080/01635580801966195 · Cited by 91
Insulin receptor expression and clinical outcome in node-negative breast cancer.
Mathieu, M. C., Clark, G. M., Allred, D. C., Goldfine, I. D., & Vigneri, R. (1997) · PubMed · Cited by 91
Gallagher, E. J., Fierz, Y., Vijayakumar, A., Haddad, N., Yakar, S., & LeRoith, D. (2011) · Oncogene · doi:10.1038/onc.2011.495 · Cited by 90
Self-citationAccelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation
Núñez, N. P., Oh, W., Rozenberg, J. M., Perella, C., Anver, M. R., Barrett, J. C., Perkins, S. L., Berrigan, D. A., Moitra, J., Varticovski, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4102 · Cited by 88
Turturro, F., Friday, E., & Welbourne, T. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-96 · Cited by 86
Kobayashi, N., Barnard, R. J., SAID, J. W., Hong-Gonzalez, J., Corman, D. M., Ku, M., Doan, N., Gui, D., Elashoff, D. A., Cohen, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5616 · Cited by 81
Hakkak, R., Holley, A. W., MacLeod, S. L., Simpson, P. M., Fuchs, G. J., Jo, C.-H., Kieber‐Emmons, T., & Korourian, S. (2005) · Breast Cancer Research · doi:10.1186/bcr1263 · Cited by 81
Controlling Hyperglycemia as an Adjunct to Cancer Therapy
Krone, C. A., & Ely, J. T. A. (2005) · Integrative Cancer Therapies · doi:10.1177/1534735404274167 · Cited by 76
Insulin-Like Growth Factor-I and Cancer Mortality in Older Men
Major, J. M., Laughlin, G. A., Kritz‐Silverstein, D. C., Wingard, D. L., & Barrett-Connor, E. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1378 · Cited by 76
Gialamas, S. P., Petridou, E. T., Tseleni‐Balafouta, S., Spyridopoulos, T. N., Matsoukis, I. L., Kondi-Pafiti, A. I., Zografos, G., & Mantzoros, C. S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.020 · Cited by 75
Enzymatic features of the glucose metabolism in tumor cells
Herling, A., König, M., Bulik, S., & Holzhütter, H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08174.x · Cited by 74
Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells
Pollak, M., Polychronakos, C., Yousefi, S., & Richard, M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90688-2 · Cited by 74
Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland
Moorehead, R. A., Hojilla, C. V., de Belle, I., Wood, G. A., Fata, J. E., Adamson, E. D., Watson, K. L. M., Edwards, D. R., & Khokha, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306894200 · Cited by 70
Tran, T. T., Gupta, N., Goh, T. T., Naigamwalla, D. Z., Chia, M. C., Koohestani, N., Mehrotra, S., McKeown‐Eyssen, G., Giacca, A., & Bruce, W. R. (2003) · PubMed · Cited by 68
Diabetes and prognosis in a breast cancer cohort
Schrauder, M. G., Fasching, P. A., Häberle, L., Lux, M. P., Rauh, C., Hein, A., Bayer, C. M., Heusinger, K., Hartmann, A., Strehl, J. D., et al. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0960-2 · Cited by 67
Serum Prostate-Specific Antigen Levels in Men With Type 2 Diabetes
Fukui, M., Tanaka, M., Kadono, M., Imai, S., Hasegawa, G., Yoshikawa, T., & Nakamura, N. (2008) · Diabetes Care · doi:10.2337/dc07-1962 · Cited by 66
Novel insulin analogues and its mitogenic potential
Zib, I., & Raskin, P. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00567.x · Cited by 63
Park, I., Lee, Y., Hwang, J., Kwon, D., Ha, J., & Park, O. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04698.x · Cited by 63
Diet-Induced Obesity and Mammary Tumor Development in MMTV-neu Female Mice
Cleary, M. P., Grande, J. P., Juneja, S. C., & Maihle, N. J. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc5002_7 · Cited by 60
Metastasis suppression by adiponectin: LKB1 rises up to the challenge
Saxena, N. K., & Sharma, D. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.3.11541 · Cited by 59
Diabetes and prostate cancer risk in the REDUCE trial
Wu, C., Moreira, D. M., Gerber, L., Rittmaster, R. S., Andriole, G. L., & Freedland, S. J. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.28 · Cited by 56
Morcavallo, A., Gaspari, M., Pandini, G., Palummo, A., Cuda, G., Larsen, M. R., Vigneri, R., & Belfiore, A. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0484 · Cited by 54
The Metabolic Syndrome and Risk of Prostate Cancer in Italy
Pelucchi, C., Serraino, D., Negri, E., Montella, M., Dellanoce, C., Talamini, R., & Vecchia, C. L. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.07.007 · Cited by 53
The Pathway from Diabetes and Obesity to Cancer, on the Route to Targeted Therapy
Gallagher, E. J., Fierz, Y., Ferguson, R. D., & LeRoith, D. (2010) · Endocrine Practice · doi:10.4158/ep10098.ra · Cited by 51
Self-citationWang, Y., Lipari, P., Wang, X., Hailey, J., Liang, L., Ramos, R., Liu, M., Pachter, J. A., Bishop, W. R., & Wang, Y. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0555 · Cited by 42
Khalid, S., Hwang, D. M., Babichev, Y., Kolli, R., Altamentova, S. M., Koren, S., Goodwin, P. J., Ennis, M., Pollak, M., Sonenberg, N., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0586-8 · Cited by 39
Fierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0091 · Cited by 39
Self-citationTworoger, S. S., ROSNER, B. A., Willett, W. C., & Hankinson, S. E. (2011) · Breast Cancer Research · doi:10.1186/bcr3040 · Cited by 38
Митин, Т., Chen, M., Zhang, Y., Moran, B. J., Dosoretz, D. E., Katin, M. J., Braccioforte, M. H., Salenius, S. A., & D'Amico, A. V. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.07.072 · Cited by 34
Insulin analogues and cancer risk: the emergence of second-generation studies
Renehan, A. G. (2011) · Diabetologia · doi:10.1007/s00125-011-2352-9 · Cited by 33
Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer
Kang, J., Chen, M., Zhang, Y., Moran, B. J., Dosoretz, D. E., Katin, M. J., Braccioforte, M. H., Salenius, S. A., & D'Amico, A. V. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.07.003 · Cited by 31
The Increased Risk of Cancer in Obesity and Type 2 Diabetes: Potential Mechanisms
Gallagher, E. J., Novosyadlyy, R., Yakar, S., & LeRoith, D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_36 · Cited by 12
Self-citation
Cited by
Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Nutrients · doi:10.3390/nu15122749 · Cited by 804
High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review
Malesza, I. J., Malesza, M., Walkowiak, J., Mussin, N., Walkowiak, D., Aringazina, R., Bartkowiak-Wieczorek, J., & Mądry, E. (2021) · Cells · doi:10.3390/cells10113164 · Cited by 782
How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases
Kopp, W. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s216791 · Cited by 660
The etiology of oxidative stress in insulin resistance
Hurrle, S., & Hsu, W. H. (2017) · Biomedical Journal · doi:10.1016/j.bj.2017.06.007 · Cited by 509
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
Legeay, S., Rodier, M., Fillon, L., Faure, S., & Clere, N. (2015) · Nutrients · doi:10.3390/nu7075230 · Cited by 351
Metadata
- Authors
- Cohen, D. H., & LeRoith, D.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2012-10
- Volume
- 19
- Issue
- 5
- Pages
- F27-F45
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2120854891
- Cited by
- 301
- References
- 173
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.